在黑色素瘤中,SMYD2通过调节H3K4三甲基化,促进氧化应激反应性脂质代谢
Bing Han1, Henan Si1, Shuyue Yang1
1Department of Dermatology and Venerology, The First Hospital of Jilin University, Jilin, China.
Journal of dermatological science
|January 10, 2026
概括
基因组甲基转移酶SMYD2通过促进抗氧化基因,从而促进脂质代谢和瘤生长,在黑色素瘤中起到瘤基因的作用. 针对SMYD2可能为黑色素瘤患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 脂质代谢对于癌症的进展至关重要,但其在黑色素瘤中的调节尚不清楚.
- 表观遗传修饰剂是癌症代谢重编程中的关键参与者.
研究的目的:
- 研究SMYD2 (一种基因组甲基转移酶) 在调节黑色素瘤中的脂质代谢和氧化应激中的作用.
- 确定SMYD2对黑色素瘤细胞行为和患者预后的影响.
主要方法:
- 分析了黑色素瘤组织中的SMYD2表达,并与预后相关.
- 在黑色素瘤细胞中进行了SMYD2敲击,并评估了增殖,迁移和亡.
- 使用ChIP-qPCR来检查SMYD2对SOD1和GPX1促进者的表观遗传修饰.
- 测量脂肪酸水平和氧化应激标志物.
主要成果:
- 高SMYD2表达与黑色素瘤预后不佳相关.
- SMYD2的淘汰减少了扩散和迁移,并增加了亡.
- SMYD2在表观遗传上调调节了SOD1和GPX1,降低了氧化应激.
- 减少氧化应激促进了脂质积累和脂肪酸合成.
结论:
- 通过表观遗传机制,SMYD2通过升调抗氧化基因 (SOD1,GPX1) 来作为黑色素瘤中的瘤基因.
- 这导致氧化应激减少,脂质代谢发生变化和瘤进展.
- 氧化压力-脂质代谢轴SMYD2为黑色素瘤提供了一个新的治疗点.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

